Edwards Lifesciences Corp

0.00 (0.0%)

Edwards Lifesciences Financial Summary

The current 0REN market cap is 73B. The company's latest EPS is 2.502 and P/E is 34.07.

Year End 31 December 20182019202020212022
Total Revenue 3.73B4.35B4.39B5.23B5.38B
Operating Income 748.2M1.15B897.6M1.57B1.71B
Net Income 722.2M1.05B823.4M1.5B1.52B
Year End 31 December 20182019202020212022
Total Assets 5.32B6.49B7.24B8.5B8.29B
Total Liabilities 2.18B2.34B2.66B2.67B2.49B
Total Equity 3.14B4.15B4.57B5.84B5.81B
Year End 31 December 20182019202020212022
Operating 926.8M1.18B1.05B1.73B1.22B
Investing 76.7M-595.8M-531.1M-1.72B252.3M
Financing -1.1B-115.6M-486.9M-356.3M-1.58B
Market Cap 73B
Price to Earnings Ratio 34.07
Price to Sales Ratio 9.62
Price to Cash Ratio 67.60
Price to Book Ratio 8.92
Dividend Yield -

Share Statistics

Shares Outstanding 608.3M
Average Volume (1 week) 1
Average Volume (1 Month) 51
52 Week Change 0.0%
52 Week High 120.00
52 Week Low 120.00
Spread (Intraday) 0 (0%)

Company Info

Company Name Edwards Lifesciences Corp
Address 1209 orange street
wilmington, delaware 19801
Website https://www.edwards.com
Industry ortho,prosth,surg appl,suply (3842)
Your Recent History
Edwards Li..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230607 18:44:25